- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06241963
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy
The Efficacy, Safety and Mechanism of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in the Treatment of Refractory Epilepsy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
All participants underwent a medical evaluation that included physical examination and routine laboratory studies before and after high definition transcranial direct current stimulation (HD-tDCS) treatment.Upon meeting the inclusion criteria and providing informed consent, each participant will complete clinical assessments by a trained investigator and HD-tDCS treatment at Anhui mental health centre.
At least 90 participants were randomized (1:1:1) to receive "bilateral active" ,"Unilateral active" or "Sham" treatment protocol. The left electrical stimulation cathode was placed over CP5 with return electrodes placed at FT7, C1, P03 and P9 . The right electrical stimulation cathode was placed over CP6 with return electrodes placed at FT8, C2, PO4 and P10 .
In the bilateral treatment group, HD-tDCS treatment was placed on the left and right sides of the brain, at least eight hours apart. Twenty 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 30 minutes,twice a day over 10 consecutive workdays. In the unilateral treatment group, HD-tDCS treatment based on Epileptic discharge is placed on either the left or right side of the brain.Ten 2-mA sessions were applied for 30 minutes,once a day over 10 consecutive workdays.Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
Before and after the tDCS treatment, the patients had receiving a battery measure of neuropsychological tests, Magnetic resonance imaging scan in multimodalities, VEEG and Resting motor threshold.
The clinical symptom of participants were followed 4 weeks and 12 weeks after the last treatment.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kai Wang, PhD
- Phone Number: +86-0551-62923704
- Email: wangkai1964@126.com
Study Contact Backup
- Name: Xingui Chen, PhD
- Phone Number: +8615955161468
- Email: chen_xin_gui@126.com
Study Locations
-
-
Anhui
-
Hefei, Anhui, China
- Recruiting
- Anhui Medical University
-
Contact:
- Kai Wang, PhD
- Phone Number: +86-0551-62923704
- Email: wangkai1964@126.com
-
Contact:
- Xingui Chen, PhD
- Phone Number: +8615955161468
- Email: chen_xin_gui@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical diagnosis of refractory epilepsy
- Right-handed and aged 18-50 years old and primary school education or above;
- No major neurological or mental illness, no head injury, alcohol dependence or drug dependence;
- During the experiment, the subjects did not smoke, drink, get sick and take psychotropic drugs, and there were no major life events that caused mood changes.
Exclusion Criteria:
- organic brain injury, neurological diseases or serious physical diseases;
- Have a history of substance abuse and drug dependence, or have used antipsychotic drugs in the past three months, and have serious suicidal tendencies;
- There are contraindications for MRI or EEG or transcranial magnetic stimulation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Unilateral real High definition transcranial direct current stimulation
The left electrical stimulation cathode was placed over CP5 with return electrodes placed at FT7, C1, P03 and P9 . The right electrical stimulation cathode was placed over CP6 with return electrodes placed at FT8, C2, PO4 and P10 . In the unilateral treatment group, HD-tDCS treatment based on Epileptic discharge is placed on either the left or right side of the brain.Ten 2-mA sessions were applied for 30 minutes,once a day over 10 consecutive workdays. |
Improvement of cortical excitability, unilateral stimulation was effective, and no side effects were observed
|
Active Comparator: Bilateral real High definition transcranial direct current stimulation
The left electrical stimulation cathode was placed over CP5 with return electrodes placed at FT7, C1, P03 and P9 . The right electrical stimulation cathode was placed over CP6 with return electrodes placed at FT8, C2, PO4 and P10 . In the bilateral treatment group, HD-tDCS treatment was placed on the left and right sides of the brain, at least eight hours apart.. Twenty 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 30 minutes,twice a day over 10 consecutive workdays. |
Improved cortical excitability, the effect was more obvious than unilateral stimulation, the effect lasted longer, and no side effects were observed
|
Sham Comparator: Sham High definition transcranial direct current stimulation
The left electrical stimulation cathode was placed over CP5 with return electrodes placed at FT7, C1, P03 and P9 . The right electrical stimulation cathode was placed over CP6 with return electrodes placed at FT8, C2, PO4 and P10. The 30 subjects were randomly divided into two groups, 15 receiving bilateral Sham HD-tDCS and 15 receiving unilateral Sham HD-tDCS. Sham HD-tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds. |
The sham stimulation is mainly used for blank control, control variables, and exclude the interference of other factors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changes of Epilepsy diary
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The reduction of seizure frequency in patients with epilepsy will constitute the primary outcome measure to evaluate the efficacy of HD-tDCS, reflecting the improvement of patients' clinical symptoms.
Patients and family members are asked to keep an epilepsy diary to record the time, duration, and status of the seizure.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changes of VEEG
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The number of discharges recorded by VEEG before and after the intervention, as well as the decrease in epileptiform discharge index, were used as indicators to evaluate the improvement of epilepsy symptoms
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of resting-state functional connectivity
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
the change of resting-state functional connectivity strength between stimulated target and the whole brain areas will be measured by functional MRI and resting-state EEG.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of resting motor threshold(RMT)
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
Previous studies have found that the resting movement threshold is an effective measure of cortical excitability in epilepsy patients, and can better predict the therapeutic effect.
An elevated resting movement threshold indicates that the treatment is responding.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of glutamate receptor-mediated intracortical facilitation (ICF)
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
ICF is a 120% RMT stimulation administered 15 ms after 90% RMT intensity stimulation, glutamate receptor-mediated intracortical promotion
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of GABA-A receptor-mediated short septal cortical inhibition (SICI)
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
SICI is 120% RMT administered 4 ms after 80% RMT intensity stimulation in response to GABA-A receptor-mediated short-interval cortical inhibition
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of GABA-B receptor-mediated long septal cortical inhibition (LICI).
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
LICI is 120% RMT administered 150ms after 120% RMT intensity stimulation in response to GABA-A receptor-mediated long-interval cortical inhibition,
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of Hamilton Depression Rating Scale (HAMD) Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The HAMD is a clinic ian-administered depression assessment and consists of 17 items with a total score range from 0 to 54.
A higher score indicates a worse outcome.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of Hamilton Anxiety Scale (HAMA) Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The HAMA is a 14-item scale to measure the severity of anxiety symptoms, where each item is rated on a scale from 0 to 4. The HAMA total score ranges from 0 to 56, with lower scores indicating less anxiety symptoms.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of MoCA Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
MoCA was developed by Nasreddine et al. based on clinical experience and reference to the MMSE cognitive items and scores, and the final version was finalized in November 2004.
We adopted a localized version (Mandarin version,includes 2 alternative versions) in line with the Chinese cultural background.A higher score indicates improvement
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of Chinese auditory learning test Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
A group consists of 15 words, read to the subject at a speed of one per second, after reading, let the patient repeat these 15 words, record the number of words spoken correctly, repeat the above behavior five times, start the timer after the end, let the patient recall 15 words after 30 minutes, and calculate the correct number,The more vocabulary is memorized, the better the score
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of TMT (Trail Making Test) Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The Trail Making Test (TMT) is divided into two parts, part A and part B. Part A requires the subject to connect 25 Numbers on the paper in sequence, and part B requires the subject to connect 25 Numbers of different colors alternately in sequence.
The time it takes for the subject to complete all the Numbers is the subject's final score.the
shorter the better.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The changes of Face associative memory Score
Time Frame: Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
The associative memory was estimated using a face-cued word association test.
In the face-cued word association test, participants studied 20 human face photographs presented individually in grayscale on a computer screen for 4 s per face.
Each photograph displayed a unique common word that the participants read aloud as each face-word pair was shown.
The participants were instructed to memorize the word associated with each face.
After the face-word pairs were presented, participants were shown the same 20 faces, individually and in a different and randomized order.
They were asked to recall the words that were presented with each face.
Each face was scored as correct or incorrect.
These processes are carried out 2 times in total.
The average number of successful answers was defined as the associative memory score.The more faces you remember correctly, the higher your score.
|
Baseline and 10 workdays post-treatment,and follow-up to 1 months and 3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AHMU-tDCS-epilepsy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transcranial Magnetic Stimulation
-
University Hospital, GrenobleUnknownHealthy | Transcranial Magnetic Stimulation | Transcranial Direct Current StimulationFrance
-
Florida State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Florida State UniversityNational Institute of Mental Health (NIMH)Recruiting
-
Florida State UniversityNational Institute of Mental Health (NIMH)Completed
-
University of RegensburgCompletedTranscranial Magnetic Stimulation
-
Institut National de la Santé Et de la Recherche...CompletedTranscranial Magnetic StimulationFrance
-
Yi YangRecruitingTranscranial Magnetic StimulationChina
-
University of ZurichUniversity Hospital Inselspital, BerneRecruitingTranscranial Magnetic Stimulation | Electric Stimulation TherapySwitzerland
-
NYU Langone HealthWithdrawn
-
Aalborg UniversityRecruitingTranscranial Magnetic Stimulation | Electroencephalography | Repetitive Transcranial Magnetic Stimulation | Motor Cortex | Pain ThresholdsDenmark
Clinical Trials on Active Comparator: Unilateral real High definition transcranial direct current stimulation
-
University of TehranRecruitingHealthy VolunteersIran, Islamic Republic of
-
University of New MexicoUniversity of Miami; The City College of New York; The Mind Research Network; New... and other collaboratorsCompletedMild Traumatic Brain InjuryUnited States
-
Monash UniversityZonMw: The Netherlands Organisation for Health Research and Development; Erasmus...Completed
-
Anhui Medical UniversityRecruitingAnxiety | Magnetic Resonance Imaging | Transcranial Direct Current StimulationChina
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMemory Disorders | Word Finding DifficultyUnited States
-
Anhui Medical UniversityRecruitingDepressive Disorder | Functional Magnetic Resonance Imaging | Transcranial Direct Current StimulationChina
-
University of Texas Rio Grande ValleyRecruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Kessler FoundationRecruitingTraumatic Brain Injury | Upper Extremity DysfunctionUnited States
-
Anhui Medical UniversityRecruitingTranscranial Direct Current Stimulation | Non Suicidal Self InjuryChina
-
Carle Foundation HospitalAmerican Heart AssociationRecruiting